Cargando…

Cost-Effectiveness Study of One-Stage Treatment of Chronic Osteomyelitis with Bioactive Glass S53P4

This study was set up to evaluate the costs of a one-stage treatment of chronic osteomyelitis using bioactive glass S53P4 versus a two-stage treatment using gentamicin-loaded PMMA beads. Furthermore, a cost-effectiveness analysis was performed from a hospital’s perspective together with the evaluati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geurts, Jan, van Vugt, Tom, Thijssen, Eline, Arts, Jacobus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804190/ https://www.ncbi.nlm.nih.gov/pubmed/31574970 http://dx.doi.org/10.3390/ma12193209

Ejemplares similares

Mid-term clinical results of chronic cavitary long bone osteomyelitis treatment using S53P4 bioactive glass: a multi-center study
por: Van Vugt, Tom A. G., et al.
Publicado: (2021)

Use of contemporary biomaterials in chronic osteomyelitis treatment: Clinical lessons learned and literature review
por: Geurts, Jan A. P., et al.
Publicado: (2020)

Assessment of Growth Reduction of Five Clinical Pathogens by Injectable S53P4 Bioactive Glass Material Formulations
por: Thijssen, Eline G. J., et al.
Publicado: (2020)

S53P4 BIOACTIVE GLASS PUTTY IN THE LOCAL TREATMENT OF CAVITARY CHRONIC OSTEOMYELITIS
por: REIS, GABRIELA NAGY BALDY DOS, et al.
Publicado: (2023)

Diagnostic value of hybrid FDG-PET/MR imaging of chronic osteomyelitis
por: Hulsen, Dennis Jan Willem, et al.
Publicado: (2022)

Resorption of the calcium phosphate layer on S53P4 bioactive glass by osteoclasts
por: van Gestel, Nicole A. P., et al.
Publicado: (2019)

Clinical Application of Antimicrobial Bone Graft Substitute in Osteomyelitis Treatment: A Systematic Review of Different Bone Graft Substitutes Available in Clinical Treatment of Osteomyelitis
por: van Vugt, T. A. G., et al.
Publicado: (2016)

Bioactive glass in the treatment of chronic osteomyelitis—a valid option?
por: Ziegenhain, Franziska, et al.
Publicado: (2021)

Bioactive glass BAG-S53P4 for the adjunctive treatment of chronic osteomyelitis of the long bones: an in vitro and prospective clinical study
por: Drago, Lorenzo, et al.
Publicado: (2013)

Treatment of Cavitary Bone Defects in Chronic Osteomyelitis: Bioactive glass S53P4 vs. Calcium Sulphate Antibiotic Beads
por: Ferrando, Albert, et al.
Publicado: (2017)

Clinical Applications of S53P4 Bioactive Glass in Bone Healing and Osteomyelitic Treatment: A Literature Review
por: van Gestel, N. A. P., et al.
Publicado: (2015)

Hybrid FDG-PET/MR imaging of chronic osteomyelitis: a prospective case series
por: Hulsen, Dennis Jan Willem, et al.
Publicado: (2019)

In vitro antibacterial activity of bioactive glass S53P4 on multiresistant pathogens causing osteomyelitis and prosthetic joint infection
por: Cunha, Mateus Trinconi, et al.
Publicado: (2018)

Antibiotic-Loaded Polymethylmethacrylate Beads and Spacers in Treatment of Orthopedic Infections and the Role of Biofilm Formation
por: van Vugt, Tom A. G., et al.
Publicado: (2019)

Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience
por: Steinhausen, Eva, et al.
Publicado: (2021)

Efficacy of S53P4 Bioactive Glass for the Secondary Obliteration of Chronically Discharging Radical Cavities
por: Kroon, Victor J., et al.
Publicado: (2023)

The Implantation of Bioactive Glass Granules Can Contribute the Load-Bearing Capacity of Bones Weakened by Large Cortical Defects
por: van Gestel, Nicole A. P., et al.
Publicado: (2019)

Bioactive glass granules S53P4 in osteotomy Le Fort I
por: de Souza Cruz, Eduardo Luis, et al.
Publicado: (2020)

A Novel Injectable Borate Bioactive Glass Cement as an Antibiotic Delivery Vehicle for Treating Osteomyelitis
por: Ding, Hao, et al.
Publicado: (2014)

Antibiotic-loaded Porous Alumina Ceramic for One-stage Surgery for Chronic Osteomyelitis
por: Fiorenza, Fabrice, et al.
Publicado: (2018)

Comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)
por: McNally, Martin
Publicado: (2021)

Biological analysis of an innovative biodegradable antibiotic eluting bioactive glass/gypsum composite bone cement for treating experimental chronic MRSA osteomyelitis
por: Mistry, Surajit, et al.
Publicado: (2022)

Management of tegmen defects with mastoid and epitympanic obliteration using S53P4 bioactive glass
por: Remangeon, Françoise, et al.
Publicado: (2020)

Bioactive glass S53P4 eradicates Staphylococcus aureus in biofilm/planktonic states in vitro
por: Grønseth, Torstein, et al.
Publicado: (2020)

Comparison of antibacterial and antibiofilm activity of bioactive glass compounds S53P4 and 45S5
por: Zhou, Peng, et al.
Publicado: (2022)

A Multicenter Retrospective Case Review of Outcomes and Complications of S53P4 Bioactive Glass
por: G. Leonard, Colin, et al.
Publicado: (2021)

Antibiotics in mastoid and epitympanic obliteration with S53P4 bioactive glass: A retrospective study
por: Alciato, Lauranne, et al.
Publicado: (2022)

Reply to McNally's comment on “Bioactive glass S53P4 vs. autologous bone graft for filling defects in patients with chronic osteomyelitis and infected non-unions – a single center experience” by Steinhausen et al. (2021)
por: Steinhausen, Eva, et al.
Publicado: (2021)

Comparative Evaluation of the Remineralizing Effects and Surface Micro hardness of Glass Ionomer Cements Containing Bioactive Glass (S53P4):An in vitro Study
por: Prabhakar, AR, et al.
Publicado: (2010)

One-Stage Biopsy, Debridement, Reconstruction, and Stabilization of Pyogenic Vertebral Osteomyelitis
por: Menon, Venugopal K., et al.
Publicado: (2014)

A rabbit osteomyelitis model for the longitudinal assessment of early post-operative implant infections
por: Odekerken, Jim CE, et al.
Publicado: (2013)

Bioactive Glasses with Low Ca/P Ratio and Enhanced Bioactivity
por: Araújo, Marco, et al.
Publicado: (2016)

The Longitudinal Assessment of Osteomyelitis Development by Molecular Imaging in a Rabbit Model
por: Odekerken, Jim C. E., et al.
Publicado: (2014)

A systematic review of the single-stage treatment of chronic osteomyelitis
por: Pincher, Bethan, et al.
Publicado: (2019)

Cutaneous and Labyrinthine Tolerance of Bioactive Glass S53P4 in Mastoid and Epitympanic Obliteration Surgery: Prospective Clinical Study
por: Bernardeschi, Daniele, et al.
Publicado: (2015)

Mastoid Obliteration with S53P4 Bioactive Glass Can Make Bonebridge Implantation Feasible: A Case Report
por: Król, Bartłomiej, et al.
Publicado: (2020)

Possible Advantages of S53P4 Bioactive Glass in the Treatment of Septic Osteoarthritis of the First Metatarsophalangeal Joint in the Diabetic Foot
por: Kastrin, Matevž, et al.
Publicado: (2021)

Bioactive Glasses: Frontiers and Challenges
por: Hench, Larry L., et al.
Publicado: (2015)

Bioactive Glass Applications in Dentistry
por: Skallevold, Hans Erling, et al.
Publicado: (2019)

Mesoporous bioactive glass composition effects on degradation and bioactivity
por: Schumacher, M., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8pl1toqjpfb6te8n5hnv5odg33